Korbinian Maria Riedhammer, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urogenital Abnormalities | 3 | 2023 | 255 | 1.540 |
Why?
|
| Urinary Tract | 2 | 2023 | 305 | 1.350 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2023 | 433 | 1.310 |
Why?
|
| Nephritis, Hereditary | 3 | 2024 | 78 | 1.260 |
Why?
|
| Collagen Type IV | 3 | 2024 | 124 | 1.080 |
Why?
|
| Embryonic Structures | 1 | 2023 | 10 | 0.910 |
Why?
|
| Nephrons | 1 | 2023 | 165 | 0.810 |
Why?
|
| Histone Code | 1 | 2022 | 160 | 0.750 |
Why?
|
| Kidney Diseases | 3 | 2023 | 2100 | 0.750 |
Why?
|
| Anodontia | 1 | 2021 | 51 | 0.720 |
Why?
|
| Ataxia | 3 | 2022 | 307 | 0.700 |
Why?
|
| Claudins | 1 | 2021 | 118 | 0.690 |
Why?
|
| Deaf-Blind Disorders | 1 | 2018 | 4 | 0.640 |
Why?
|
| Dystonia | 2 | 2020 | 378 | 0.620 |
Why?
|
| Nephrotic Syndrome | 5 | 2022 | 380 | 0.610 |
Why?
|
| Optic Atrophy | 1 | 2018 | 78 | 0.590 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 259 | 0.580 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 1623 | 0.530 |
Why?
|
| Phenotype | 14 | 2024 | 16712 | 0.490 |
Why?
|
| Zebrafish | 3 | 2023 | 3035 | 0.470 |
Why?
|
| Hypogonadism | 1 | 2021 | 801 | 0.470 |
Why?
|
| Kidney | 6 | 2023 | 7070 | 0.430 |
Why?
|
| Abnormalities, Multiple | 4 | 2022 | 1424 | 0.430 |
Why?
|
| Congenital Disorders of Glycosylation | 2 | 2021 | 51 | 0.330 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2022 | 698 | 0.330 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 2 | 2021 | 334 | 0.280 |
Why?
|
| Mutation | 8 | 2024 | 30208 | 0.260 |
Why?
|
| Genetic Variation | 4 | 2021 | 6611 | 0.250 |
Why?
|
| Speech Production Measurement | 3 | 2011 | 99 | 0.250 |
Why?
|
| Developmental Disabilities | 4 | 2021 | 1519 | 0.220 |
Why?
|
| Ubiquinone | 2 | 2022 | 181 | 0.220 |
Why?
|
| Proteinuria | 2 | 2024 | 606 | 0.220 |
Why?
|
| Transcription Factor TFIIA | 1 | 2022 | 17 | 0.210 |
Why?
|
| Membrane Proteins | 2 | 2022 | 7850 | 0.200 |
Why?
|
| Hematuria | 1 | 2024 | 232 | 0.200 |
Why?
|
| Prader-Willi Syndrome | 1 | 2023 | 80 | 0.200 |
Why?
|
| Situs Inversus | 1 | 2022 | 63 | 0.200 |
Why?
|
| Genetic Association Studies | 5 | 2024 | 2744 | 0.190 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2022 | 2898 | 0.190 |
Why?
|
| Mitochondrial Diseases | 2 | 2022 | 344 | 0.190 |
Why?
|
| Intranuclear Space | 1 | 2021 | 15 | 0.190 |
Why?
|
| Fucose | 1 | 2021 | 115 | 0.180 |
Why?
|
| Codon, Terminator | 1 | 2021 | 125 | 0.180 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2019 | 20 | 0.170 |
Why?
|
| Holoprosencephaly | 1 | 2019 | 22 | 0.170 |
Why?
|
| Homeodomain Proteins | 2 | 2020 | 2429 | 0.170 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2021 | 437 | 0.170 |
Why?
|
| Vestibular Diseases | 1 | 2022 | 232 | 0.170 |
Why?
|
| Autoantigens | 1 | 2024 | 886 | 0.160 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2020 | 279 | 0.160 |
Why?
|
| Plasma Exchange | 1 | 2020 | 160 | 0.160 |
Why?
|
| Eye Abnormalities | 1 | 2021 | 242 | 0.160 |
Why?
|
| Face | 2 | 2022 | 1029 | 0.160 |
Why?
|
| Disorders of Sex Development | 1 | 2019 | 129 | 0.160 |
Why?
|
| Endopeptidases | 1 | 2022 | 760 | 0.160 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2020 | 124 | 0.160 |
Why?
|
| Pedigree | 3 | 2021 | 4535 | 0.150 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2020 | 131 | 0.150 |
Why?
|
| POU Domain Factors | 1 | 2018 | 47 | 0.150 |
Why?
|
| Hematologic Diseases | 1 | 2022 | 500 | 0.150 |
Why?
|
| Repressor Proteins | 2 | 2020 | 2974 | 0.150 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2021 | 385 | 0.150 |
Why?
|
| Laryngectomy | 2 | 2011 | 245 | 0.150 |
Why?
|
| Ichthyosis | 1 | 2018 | 59 | 0.150 |
Why?
|
| Child | 15 | 2024 | 80567 | 0.150 |
Why?
|
| Cytoplasm | 2 | 2020 | 1498 | 0.150 |
Why?
|
| Lysine | 1 | 2022 | 994 | 0.140 |
Why?
|
| Child, Preschool | 13 | 2024 | 42509 | 0.140 |
Why?
|
| Epilepsy | 3 | 2022 | 3317 | 0.140 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 3594 | 0.140 |
Why?
|
| Infant | 12 | 2024 | 36424 | 0.140 |
Why?
|
| Esophageal Atresia | 1 | 2020 | 226 | 0.140 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2019 | 309 | 0.130 |
Why?
|
| Actins | 2 | 2020 | 2060 | 0.130 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 273 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 1130 | 0.120 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 667 | 0.120 |
Why?
|
| Heart Defects, Congenital | 2 | 2022 | 4712 | 0.120 |
Why?
|
| Humans | 40 | 2024 | 766000 | 0.120 |
Why?
|
| Seizures | 4 | 2022 | 2997 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 606 | 0.120 |
Why?
|
| DNA Helicases | 1 | 2020 | 852 | 0.120 |
Why?
|
| Brain | 2 | 2021 | 27171 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2020 | 810 | 0.120 |
Why?
|
| Homozygote | 1 | 2019 | 1775 | 0.120 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 9600 | 0.110 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 1674 | 0.110 |
Why?
|
| Mutation, Missense | 5 | 2021 | 2590 | 0.110 |
Why?
|
| Speech Intelligibility | 2 | 2011 | 80 | 0.110 |
Why?
|
| Genetic Testing | 3 | 2024 | 3592 | 0.110 |
Why?
|
| Family Health | 1 | 2018 | 1253 | 0.110 |
Why?
|
| Lymphedema | 1 | 2020 | 525 | 0.110 |
Why?
|
| Speech, Alaryngeal | 2 | 2011 | 32 | 0.100 |
Why?
|
| Adolescent | 10 | 2024 | 88808 | 0.100 |
Why?
|
| Autistic Disorder | 1 | 2022 | 1237 | 0.100 |
Why?
|
| Tuberous Sclerosis | 1 | 2020 | 1039 | 0.100 |
Why?
|
| Larynx, Artificial | 2 | 2011 | 70 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 3664 | 0.100 |
Why?
|
| Histones | 1 | 2022 | 2591 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 4399 | 0.090 |
Why?
|
| Female | 23 | 2024 | 396158 | 0.090 |
Why?
|
| Syndrome | 3 | 2022 | 3270 | 0.090 |
Why?
|
| Speech Acoustics | 1 | 2011 | 155 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2022 | 2504 | 0.090 |
Why?
|
| Voice Quality | 1 | 2011 | 226 | 0.080 |
Why?
|
| Muscle Weakness | 2 | 2022 | 412 | 0.080 |
Why?
|
| Young Adult | 8 | 2024 | 59857 | 0.080 |
Why?
|
| Telephone | 2 | 2009 | 627 | 0.080 |
Why?
|
| Adult | 12 | 2024 | 223106 | 0.080 |
Why?
|
| Speech Recognition Software | 1 | 2008 | 74 | 0.080 |
Why?
|
| Facies | 2 | 2019 | 224 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2023 | 14455 | 0.080 |
Why?
|
| Male | 19 | 2024 | 363855 | 0.080 |
Why?
|
| Animals | 8 | 2023 | 168775 | 0.070 |
Why?
|
| Voice Disorders | 1 | 2011 | 286 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2021 | 4910 | 0.070 |
Why?
|
| Speech Disorders | 1 | 2009 | 178 | 0.070 |
Why?
|
| Laryngeal Neoplasms | 1 | 2011 | 514 | 0.070 |
Why?
|
| Steroids | 2 | 2022 | 934 | 0.070 |
Why?
|
| Germany | 2 | 2024 | 882 | 0.070 |
Why?
|
| Podocytes | 2 | 2021 | 389 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 12802 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9524 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 18076 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2023 | 12128 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2009 | 698 | 0.060 |
Why?
|
| Hyperphagia | 1 | 2023 | 139 | 0.050 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2022 | 72 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 81821 | 0.050 |
Why?
|
| Pseudopodia | 1 | 2020 | 168 | 0.040 |
Why?
|
| Genes, X-Linked | 1 | 2020 | 129 | 0.040 |
Why?
|
| Still's Disease, Adult-Onset | 1 | 2020 | 23 | 0.040 |
Why?
|
| Penetrance | 1 | 2022 | 388 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2023 | 23600 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 292 | 0.040 |
Why?
|
| Methylation | 1 | 2022 | 1074 | 0.040 |
Why?
|
| Genetic Research | 1 | 2020 | 173 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2021 | 288 | 0.040 |
Why?
|
| Histone Demethylases | 1 | 2022 | 328 | 0.040 |
Why?
|
| Alleles | 2 | 2020 | 6892 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26280 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 709 | 0.040 |
Why?
|
| Middle Aged | 8 | 2022 | 223025 | 0.040 |
Why?
|
| Glycosylation | 1 | 2021 | 1099 | 0.040 |
Why?
|
| Kidney Glomerulus | 1 | 2020 | 567 | 0.040 |
Why?
|
| Haploinsufficiency | 1 | 2020 | 333 | 0.040 |
Why?
|
| Ear | 1 | 2018 | 172 | 0.040 |
Why?
|
| Aged | 6 | 2022 | 171161 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2020 | 777 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 41675 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2021 | 714 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2011 | 5088 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2021 | 902 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2021 | 26379 | 0.030 |
Why?
|
| Heterozygote | 1 | 2022 | 2796 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 1562 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1186 | 0.030 |
Why?
|
| Fingers | 1 | 2018 | 509 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2021 | 2197 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 36545 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 2392 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 1883 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2879 | 0.030 |
Why?
|
| Drosophila | 1 | 2020 | 1506 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2815 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 3423 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2021 | 4161 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 1725 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1882 | 0.020 |
Why?
|
| Gestational Age | 1 | 2019 | 3616 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2022 | 3426 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2024 | 54797 | 0.020 |
Why?
|
| Automation | 1 | 2011 | 585 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2019 | 5383 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5194 | 0.020 |
Why?
|
| Proteins | 1 | 2023 | 5994 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2022 | 81542 | 0.020 |
Why?
|
| Reading | 1 | 2011 | 540 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2019 | 2417 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2011 | 20135 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 2158 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2020 | 4213 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15545 | 0.020 |
Why?
|
| Sepsis | 1 | 2020 | 2604 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 2611 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 7425 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 4960 | 0.010 |
Why?
|
| Skin | 1 | 2018 | 4482 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2011 | 1457 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2021 | 65199 | 0.010 |
Why?
|
| Liver | 1 | 2019 | 7558 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2011 | 6324 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 13463 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 13082 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29904 | 0.010 |
Why?
|
| Pregnancy | 1 | 2019 | 30227 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 15401 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 14644 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 40100 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 59493 | 0.000 |
Why?
|